BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 64041)

  • 1. [Intraarterial bleomycin therapy on squamous cell carcinomas of the oral cavity. Clinico-pathological investigations (author's transl)].
    Höltje WJ; Burkhardt A; Gebbers JO; Maerker R
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Dec; 88(1):69-90. PubMed ID: 64041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intra-arterial bleomycin therapy on squamous cell carcinoma of the oral cavity. Biopsy and autopsy examinations.
    Burkhardt A; Höltje WJ
    J Maxillofac Surg; 1975 Dec; 3(4):217-30. PubMed ID: 54400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technique and clinical assessment of the intra-arterial chemotherapy of squamous cell carcinoma (author's transl)].
    Günther R; Müller W
    Arch Geschwulstforsch; 1982; 52(2):113-6. PubMed ID: 6179496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination therapy for advanced oral squamous cell carcinoma with radiation and bleomycin. I. Primary regression and early mucosal reaction (author's transl)].
    Takeda M; Horiuchi J; Okuyama T; Matsubara S; Shibuya H
    Newsl Int Coll Dent India Sect; 1980 Jan; 40(1):36-42. PubMed ID: 6154281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effects of NK 631 in malignant tumors of the oral cavity (author's transl)].
    Kawahira K; Dohhara Y; Sugihara K; Yamada K; Fujinami Y; Saku T; Yamashita S
    Jpn J Antibiot; 1979 Jan; 32(1):138-48. PubMed ID: 84884
    [No Abstract]   [Full Text] [Related]  

  • 6. [The remission of extensive cancers of the mouth and oropharynx with intra-arterial polychemotherapy with vincristine, methotrexate, bleomycin, cisplatin (VMBP)].
    Mika H
    Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):520-3. PubMed ID: 6183545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antineoplastic chemotherapy of head and neck tumors (author's transl)].
    Weidauer H
    HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity.
    Yamamoto E; Kohama G; Sunakawa H; Iwai M; Hiratsuka H
    Cancer; 1983 Jun; 51(12):2175-80. PubMed ID: 6189571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticancer chemotherapy apropos of bleomycin].
    Miyake H; Suzuki Y; Kunishige N
    Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):677-89. PubMed ID: 4123695
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular lesions following perfusion with bleomycin. Electron-microscopic observations.
    Burkhardt A; Höltje WJ; Gebbers JO
    Virchows Arch A Pathol Anat Histol; 1976 Dec; 372(3):227-36. PubMed ID: 65049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technique and problems of long-term perfusion in the intra-arterial chemotherapy of squamous cell carcinoma of the mouth (author's transl)].
    Günther R; Müller W
    Zahn Mund Kieferheilkd Zentralbl; 1981; 69(1):31-6. PubMed ID: 6168137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of oral and maxillofacial squamous cell carcinomas by zhenguangmycin---with discussion on the similarities and differences between zhenguangmycin and bleomycin (author's transl)].
    Zhonghua Kou Qiang Ke Za Zhi; 1979 Jun; 14(2):77-9. PubMed ID: 95503
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the clinical effect of NK 631 for oral-cavity cancers (author's transl)].
    Ohashi Y; Abe M; Saito K; Mizutani H; Onishi S; Ueda N
    Jpn J Antibiot; 1979 Feb; 32(2):259-64. PubMed ID: 86622
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preoperative application of NK 631 for carcinoma of oral cavity (author's transl)].
    Yamamoto E; Sunakawa H; Kohama GI
    Jpn J Antibiot; 1979 Feb; 32(2):253-8. PubMed ID: 86621
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized EORTC trial comparing intra-arterial infusion with methotrexate vs bleomycin as initial therapy in carcinoma of the oral cavity.
    Molinari R; Jortay A; Sancho-Garnier H; Brugere J; Demard M; Desaulty A; Jausseran M; Gignoux B; Brossard-Legrand M
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):807-12. PubMed ID: 6185343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Formation of giant cells in oral squamous cell carcinoma during bleomycin treatment: enzymehistochemical, electronmicroscopic and ultrahistochemical investigations (author's transl)].
    Burkhardt A; Bommer G; Gebbers JO; Höltje WJ
    Virchows Arch A Pathol Anat Histol; 1976 Feb; 369(3):197-214. PubMed ID: 56803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity suppression by bleomycin-methotrexate combined treatment in patients with epidermoid carcinoma of the oral cavity.
    Bitter K
    J Maxillofac Surg; 1974 Mar; 2(1):35-9. PubMed ID: 4133357
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
    Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
    Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions.
    Shingaki S; Kawasaki T; Nagamine T; Kanamaru T; Yokobayashi T; Nakajima T
    J Oral Surg; 1980 Dec; 38(12):886-92. PubMed ID: 6160232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathohistologic studies of serial sections of squamous cell cancer of the oral cavity and oropharynx following cytostatic induction therapy with bleomycin and cisplatin].
    Bettinger R; Meyer-Breiting E; Klima A
    Laryngol Rhinol Otol (Stuttg); 1988 Nov; 67(11):580-5. PubMed ID: 2467153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.